Edition:
United States

21st North Inc (ULGX.PK)

ULGX.PK on OTC Markets Group

0.00USD
15 Dec 2017
Change (% chg)

-- (--)
Prev Close
$0.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
25,360
52-wk High
$0.00
52-wk Low
$0.00

Chart for

About

21st North Inc., formerly Urologix Inc., was engaged in developing, manufacturing, marketing and distributing medical products. The Company offered its products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia (BPH). The Company has no operations. The Company intends to dissolve.
No analyst recommendations are available for .

Overall

Beta: 5.51
Market Cap(Mil.): $0.03
Shares Outstanding(Mil.): 21.82
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 27.83 16.04
EPS (TTM): -- -- --
ROI: -- 10.00 34.69
ROE: -- 15.21 15.46

Earnings vs. Estimates